- Home
- WHG vs ALEC Comparison
WHG vs ALEC Comparison
Compare WHG & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHG | ALEC |
|---|---|---|
| Founded | 1983 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.6M | 200.8M |
| IPO Year | 2002 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WHG | ALEC |
|---|---|---|
| Price | $17.97 | $1.95 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 12.2K | ★ 1.1M |
| Earning Date | 02-11-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.31% | N/A |
| EPS Growth | ★ 154.57 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $96,243,000.00 | $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.97 | ★ N/A |
| Revenue Growth | 4.20 | ★ 12.26 |
| 52 Week Low | $14.00 | $0.87 |
| 52 Week High | $18.99 | $3.40 |
Technical Indicators
Market Signals| Indicator | WHG | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 52.30 | 69.71 |
| Support Level | $17.89 | $1.77 |
| Resistance Level | $18.27 | $2.00 |
| Average True Range (ATR) | 0.49 | 0.11 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 62.31 | 80.95 |
Price Performance
Historical ComparisonAbout WHG Westwood Holdings Group Inc
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.